
|Articles|October 18, 2007
First integrase inhibitor Isentress gets regulatory green light
Raltegravir (Isentress, Merck) receives FDA approval for HIV treatment.
Advertisement
Accelerated approval for Merck's raltegravir (
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Embedded Pharmacists Are Vital Yet Underutilized in Diabetes Care
2
Executive Order Calls for Realignment of Childhood Vaccines
3
The Prodigious PBM Pivot: How Supply Chain Entities Will Move Forward After CAA 2026
4
Heat and Older Adults: What Pharmacists Need to Know
5





























































